FRISINA, Nicola
 Distribuzione geografica
Continente #
NA - Nord America 3.758
EU - Europa 3.081
AS - Asia 804
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 2
OC - Oceania 2
Totale 7.656
Nazione #
US - Stati Uniti d'America 3.733
SE - Svezia 944
IE - Irlanda 915
CN - Cina 655
UA - Ucraina 390
DE - Germania 325
FI - Finlandia 159
GB - Regno Unito 134
IT - Italia 111
SG - Singapore 88
IN - India 42
BE - Belgio 27
CA - Canada 25
RU - Federazione Russa 20
CZ - Repubblica Ceca 17
FR - Francia 14
IR - Iran 14
CL - Cile 5
CH - Svizzera 4
NL - Olanda 4
PL - Polonia 4
AT - Austria 3
BG - Bulgaria 3
EU - Europa 3
AU - Australia 2
HK - Hong Kong 2
BR - Brasile 1
DK - Danimarca 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JP - Giappone 1
LU - Lussemburgo 1
LV - Lettonia 1
NG - Nigeria 1
RO - Romania 1
TR - Turchia 1
Totale 7.656
Città #
Dublin 915
Jacksonville 847
Chandler 778
Nyköping 456
Beijing 273
Ashburn 188
Cambridge 150
Princeton 150
Medford 141
Des Moines 120
Ann Arbor 114
Boardman 108
Dearborn 86
Lancaster 61
New York 58
Bremen 52
Shenyang 48
Singapore 47
Wilmington 47
Jinan 46
Woodbridge 45
Los Angeles 29
Hebei 28
Brussels 27
San Mateo 27
Zhengzhou 27
Nanjing 25
Tianjin 23
Pune 22
Taizhou 22
Turin 22
Haikou 21
Ningbo 19
Augusta 18
Ottawa 17
Brno 16
Hangzhou 16
Houston 14
Lanzhou 13
Taiyuan 13
Seattle 12
Falls Church 11
Jiaxing 11
Munich 11
Nanchang 11
Ardabil 10
Helsinki 10
Leawood 10
Changsha 9
Fuzhou 9
Hyderabad 9
Monmouth Junction 9
Guangzhou 8
Auburn Hills 7
Messina 7
Clearwater 6
Mumbai 6
Norwalk 6
Rome 6
Washington 5
Catania 4
Chaoyang 4
Saint Petersburg 4
Florence 3
Jeffries 3
Montreal 3
Novokuznetsk 3
Paterno 3
Polverigi 3
Rho 3
Sofia 3
Toronto 3
Vienna 3
Aci Castello 2
Cairo Montenotte 2
Central 2
Changle 2
Den Haag 2
Gropello Cairoli 2
Hanover 2
Hefei 2
Kemerovo 2
London 2
Montreux 2
Phoenix 2
Radomsko 2
Redmond 2
Rio Saliceto 2
Strasbourg 2
Viagrande 2
Vittoria 2
Aci Sant'antonio 1
Amsterdam 1
Birmingham 1
Bologna 1
Bolzano 1
Boston 1
Brooklyn 1
Budapest 1
Cagliari 1
Totale 5.389
Nome #
Cell proliferation/cell death balance in renal cell cultures after exposure to a static magnetic field 85
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 85
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 82
Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin 82
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 81
Effects of Homocysteine on Proliferation, Necrosis, and Apoptosis of Vascular Smooth Muscle Cells in Culture and Influence of Folic Acid 81
Recombinant human erythropoietin stimulates angiogenesis and healing of ischemic skin wounds 77
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 76
Behavior of vascular endothelial growth factor and erythropoietin throughout the menstrual cycle in healthy women. 76
Statins in the prevention of cardiovascular events in patients with renal failure. 73
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 71
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 70
Aldosterone and prolactin secretion. II. Plasma renin activity, blood potassium and cortisol levels following administration of sulpiride in normal subjects 69
Aquaporin-2 water channels in spontaneously hypertensive rats 69
Effect of two different models of hemodiafiltration potassium removal on QT dispersion 68
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 68
Circadian rhythm of hydration in healthy subjects and uremic patients studied by bioelectrical impedance analysis 68
AQP1 in red blood cells of uremic patients during hemodialytic treatment 68
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 68
Recombinant erythropoietin and hypertension 68
ASSETTO EMATOLOGICO DI UN GRUPPO DI SOGGETTIAFFETTI DA MORBO DI COOLEY:STUDIO DEL COMPORTAMENTO DELL'ERITROPOIETINA PLASMATICA 68
Effect of a calcium antagonist, nifedipine, on the cold pressor test in normal subjects 65
A trigonometric approximation method for the monostatic radar cross section 65
ELIZABETHAN STUDIES IN ITALY IN 1989 AND 1990 64
Administration of recombinant erythropoietin determines increase of peripheral resistances in patients with hypovolemic shock 64
Association between primary hyperprathyroidism (p-hyperPTH) and nodular toxic goiter (NTG): a prospective study at an outpatient service for osteoporosis 63
Alterations in induced potassium calcium efflux in the erythrocytes of patients with autosomal dominant polycystic kidney disease and hypertension 63
Association of primary hyperparathyoidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service. 62
Are there potential non-lipid-lowering uses of statins in the kidney? 62
Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in ESRD patients 62
Correlation between quality of life assessment and a personality neurobiologic model in dialyzed patients 62
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 61
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 61
Hashimoto's thyroiditis is a frequent association of primary hyperparathyroidism, of which it modifies biochemical and bone density indices 60
Flushing due to calcitonin and the opioid system 60
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 60
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 60
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 59
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 59
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 58
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 58
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 58
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 58
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 58
Nonrobertsonian translocation t(6;11) is associated with infertility in an oligoazoospermic male 58
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 58
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 58
ATTIVITÀ RENINICA, ANGIOTENSINA II, ALDOSTERONE PLASMATICI IN SOGGETTI ANZIANI. 58
Statins in nephrotic syndrome: a new weapon against tissue injury. 57
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 57
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 56
Therapy with vasopressin receptor antagonists: the aquaretics 56
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 55
Recombinant erythropoietin and cardiovascular risk in uremia. 55
Chromosomal damage and atherosclerosis. A protective effect from simvastatin. 55
The behaviour of serum triiodothyronine in autonomous thyroid nodules and its relationship with the clinical feature 55
From the oxygen to the organ protection: erythropoietin as protagonist in internal medicine 55
Hypokalemic myopathy in pseudohyperaldosteronism induced by fluoroprednisolone-containing nasal spray. 54
Cardiovascular effects of raloxifene hydrochloride 54
Hashimoto's thyroiditis (HT) is a frequent association of primary hyperparathyroidism (p-hyperPTH), of which it modifies biochemical and bone density indices 53
Reduced bcl-2 concentrations in hypertensive patients after lisinopril or nifedipine administration 53
Does captopril have a direct pro-apoptotic effect? 53
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 53
MARKERS OF ENDOTHELIAL AND PLATELET STATUS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND PLYCYTHEMIA VERA 52
Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients 52
Urinary excretion of aquaporin-2 water channel during pregnancy 52
Positive effects of the phytoestrogen genistein on bone metabolism in postmenopausal women 51
Effect of unsaturated fatty acids on basal plasma renin activity and afterpostural stimulation 51
The effect of two different protocols of potassium haemodiafiltration on QT dispersion 51
Kidney aging: From phenotype to genetics 51
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 51
Cold pressor test raises serum concentrations of ICAM-1, VCAM- 1, and E-selectin in normotensive and hypertensive patients 51
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a randomized, double-blind, placebo-controlled study 51
Effect of interleukin 8 and ICAM-1 on calcium-dependent outflow of K+ in erythrocytes from subjects with essential hypertension 50
Rapid and transient lymphocytopenia after i.v. administration of high doses of human recombinant erythropoietin 50
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 50
Hemostasis and fibrinolysis factors in first-degree relatives of patients with type 2 diabetes without hypertension 50
Increased indexes of thrombin activation in advanced stages of hypertension 50
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 50
Cardiovascular remodeling, apoptosis, and drugs 50
Long-term transdermal estrogen therapy improves lipid profile but not insulin resistance in healthy postmenopausal women 49
Renal failure from mitochondrial cytopathies 49
DIFFERENT ANSWER TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN ANEPHRIC AND NONANEPHRIC HEMODIALYZED PATIENTS 49
Rapid, progressive deterioration of renal function following erroneousADMINISTRATION OF HIGH DOSES OF SUBCUTANEOUS RECOMBINANT ERYTHROPOIETIN] 49
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 49
Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major 49
Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women 49
The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis. 49
Effect of a prostacyclin analogue, iloprost, on urinary aquaporin-2 excretion in humans 49
Osteoprotegerin, IL-6, IL-1, TNF-alpha and TGF-beta concentrations during acetate-free biofiltration 48
INFLUENCE OF THE TREATMENT WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN ON PLASMA-CONCENTRATION OF INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA IN HEMODIALYZED SUBJECTS 48
Gastro-intestinal permeability is increased in patients with limited systemic sclerosis 48
Effects of lisinopril administration on blood bcl-2 concentrations in patients with immunoglobulin A nephropathy 48
Positive effects of the isoflavone genistein on cardiovascular system in osteopenic, postmenopausal women 47
Endothelin-1 production in umbilical arteries from hypertensive pregnant women 47
Loss of circadian rhythm in erythropoietin production in a patient with renal erythropoietin secreting neoplasia 47
Effetti di un fitoestrogeno (Genisteina) su marcatori citogenetici in donne in post menopausa. 47
Management of patients after renal graft loss: an open question for nephrologists. 47
Growth factors and hematopoiesis :Physiopathology and clinical applications 46
DOES ERYTHROPOIETIN AUGMENT THE CA2+-MEDIATED K+ FLOW INTO THE RED-BLOOD-CELLS IN NORMOTENSIVE AND HYPERTENSIVE SUBJECTS 46
Totale 5.831
Categoria #
all - tutte 30.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.483


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020960 0 0 8 102 6 84 182 146 11 222 195 4
2020/2021936 141 8 244 41 19 135 4 109 0 69 124 42
2021/20221.213 5 263 13 26 62 10 59 39 56 225 133 322
2022/20232.829 203 272 128 221 251 279 25 193 1.107 34 85 31
2023/2024619 48 99 41 58 35 154 26 34 4 35 9 76
2024/202586 60 25 1 0 0 0 0 0 0 0 0 0
Totale 7.717